1. Home
  2. DBVT vs LAW Comparison

DBVT vs LAW Comparison

Compare DBVT & LAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • LAW
  • Stock Information
  • Founded
  • DBVT 2002
  • LAW 2013
  • Country
  • DBVT France
  • LAW United States
  • Employees
  • DBVT N/A
  • LAW N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • LAW Computer Software: Prepackaged Software
  • Sector
  • DBVT Health Care
  • LAW Technology
  • Exchange
  • DBVT Nasdaq
  • LAW Nasdaq
  • Market Cap
  • DBVT 260.5M
  • LAW 249.3M
  • IPO Year
  • DBVT N/A
  • LAW 2021
  • Fundamental
  • Price
  • DBVT $15.48
  • LAW $6.21
  • Analyst Decision
  • DBVT Buy
  • LAW Buy
  • Analyst Count
  • DBVT 4
  • LAW 2
  • Target Price
  • DBVT $14.81
  • LAW $6.75
  • AVG Volume (30 Days)
  • DBVT 94.7K
  • LAW 151.3K
  • Earning Date
  • DBVT 11-05-2025
  • LAW 11-05-2025
  • Dividend Yield
  • DBVT N/A
  • LAW N/A
  • EPS Growth
  • DBVT N/A
  • LAW N/A
  • EPS
  • DBVT N/A
  • LAW N/A
  • Revenue
  • DBVT $3,800,000.00
  • LAW $148,024,000.00
  • Revenue This Year
  • DBVT $1,743.46
  • LAW $7.13
  • Revenue Next Year
  • DBVT $1,044.34
  • LAW $6.25
  • P/E Ratio
  • DBVT N/A
  • LAW N/A
  • Revenue Growth
  • DBVT N/A
  • LAW 4.05
  • 52 Week Low
  • DBVT $2.21
  • LAW $3.31
  • 52 Week High
  • DBVT $15.95
  • LAW $6.81
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 87.03
  • LAW 51.09
  • Support Level
  • DBVT $9.19
  • LAW $5.90
  • Resistance Level
  • DBVT $14.44
  • LAW $6.54
  • Average True Range (ATR)
  • DBVT 0.84
  • LAW 0.25
  • MACD
  • DBVT 0.64
  • LAW -0.11
  • Stochastic Oscillator
  • DBVT 100.00
  • LAW 8.24

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

Share on Social Networks: